Treatment of Patients With Alcoholism and Attention Deficit Disorder

NCT00261872 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

100

Enrollment

NIH

Sponsor class

Conditions

Alcoholism
Attention Deficit Disorder

Interventions

DRUG: Methylphenidate

Sponsor

National Institute on Alcohol Abuse and Alcoholism (NIAAA)